Related by context. All words. (Click for frequent words.) 74 comorbidity 70 comorbid conditions 69 comorbidities 69 comorbid depression 68 comorbid psychiatric 68 psychiatric comorbidity 67 comorbid anxiety 67 affective disorders 66 affective psychoses 66 depressive symptomatology 65 Comorbid 65 dysthymia 65 psychosocial functioning 65 affective psychosis 65 syndromal 64 psychiatric comorbidities 64 suicidal ideation 64 subsyndromal 64 comorbid substance 64 nonpsychotic 64 somatoform disorders 64 comorbid disorders 63 schizophrenia schizoaffective disorder 63 chronicity 63 euthymic patients 63 dysthymic disorder 63 Depressive symptoms 63 symptom severity 63 HRQOL 62 alexithymia 62 nonpsychiatric 62 somatic symptoms 62 HRQoL 62 premorbid 61 EQ 5D 61 sociodemographic characteristics 61 autonomic dysfunction 61 covariate 61 % CI #.#-#.# [006] 61 CI = 61 Suicidal ideation 61 subscales 61 nonadherence 61 androgen deficiency 61 multivariate analyzes 61 somatoform disorder 61 suicide attempters 61 hypochondriasis 61 psychiatric morbidity 61 Exclusion criteria 61 MetS 61 unipolar depression 61 DSM IV diagnosis 60 OSAHS 60 Major depressive disorder 60 confidence interval #.#-#.# 60 Personality disorders 60 depressive symptoms 60 co morbidities 60 euthymic 60 psychotic disorders 60 nondepressed 60 emotional lability 60 somatic complaints 60 univariate analyzes 59 hypertension diabetes mellitus 59 somatization disorder 59 sociodemographic factors 59 symptomatology 59 affective disorder 59 QoL 59 Comorbidity 59 LUTS 59 DSM IV Axis 59 T2DM 59 covariates 59 impaired cognition 59 atopic 59 neurocognitive impairment 59 schizophreniform disorder 59 dysphoric 59 elevated IOP 59 MGUS 59 df = 59 Brief Psychiatric 59 % CI #.#-#.# [007] 58 subclinical hypothyroidism 58 adenotonsillectomy 58 DSM IV criteria 58 haematologic 58 TEAEs 58 hypersomnia 58 akathisia 58 MMSE score 58 psychopathology 58 hyperarousal 58 % CI #.#-#.# [008] 58 neovascular glaucoma 58 atherothrombotic disease 58 highly heritable 58 somatization 58 extrapyramidal symptoms 58 generalized tonic clonic seizures 58 psychotic symptoms 58 MMSE scores 58 prevalences 58 habitual snoring 58 externalizing disorders 58 internalizing disorders 58 % CI #.#-#.# [005] 58 neurocognitive function 58 Excessive daytime sleepiness 58 HRQL 58 suicidality 58 DSM IV diagnostic 58 hypomanic symptoms 58 IPAH 58 logistic regression model 58 carotid stenosis 58 systolic hypertension 58 psychiatric diagnoses 58 Cognitive impairment 58 dysuria 58 familial aggregation 58 psychosocial variables 57 poststroke 57 #q# deletion syndrome 57 psychiatric disorders 57 confidence intervals CIs 57 logistic regression analysis 57 Major Depressive Disorder 57 sub syndromal 57 subclinical atherosclerosis 57 nonfatal MI 57 Comorbidities 57 underdiagnosis 57 juvenile idiopathic arthritis JIA 57 dissociative symptoms 57 macroalbuminuria 57 SRBD 57 depressive symptom 57 comorbid psychiatric disorders 57 generalized anxiety disorder 57 substance induced psychosis 57 p = .# [002] 57 comorbid diagnoses 57 confidence interval CI 57 DSM IV TR 57 mania hypomania 57 chronic relapsing 57 bivariate analyzes 57 inattention hyperactivity 57 diagnosable 57 Anxiety disorders 57 multivariable adjusted 57 Sociodemographic 57 attention-deficit/hyperactivity disorder 57 neuropsychological deficits 57 comorbid illnesses 57 atherothrombotic 57 syndromic 57 Neuroticism 57 dysthymic 57 HRCT 57 TMS Therapy 57 Social Phobia 57 subscore 57 neurocognitive deficits 57 histologically confirmed 57 % CI #.#-#.# [004] 57 multivariate adjustment 57 predisposing factor 57 subscale scores 57 non affective psychosis 57 arterial thromboembolic events 57 COPD exacerbation 57 Heritability 56 puerperal psychosis 56 autoimmune thyroid 56 Generalized Anxiety Disorder 56 diabetes mellitus DM 56 Antisocial Personality Disorder 56 neurocognitive functioning 56 Oppositional Defiant Disorder 56 GH deficiency 56 thyrotropin levels 56 NIHSS score 56 NNT = 56 detrusor overactivity 56 frequent awakenings 56 methotrexate monotherapy 56 unfavorable prognostic 56 partial onset seizures 56 prodromal symptoms 56 typical antipsychotics 56 hypovitaminosis D 56 HAM D# 56 psychopathological symptoms 56 schizotypal 56 AUDs 56 univariate analysis 56 primary aldosteronism 56 neuropsychological impairments 56 microalbuminuria 56 elevated LDH 56 Montgomery Åsberg Depression 56 episodic migraine 56 bulimia nervosa 56 Mood disorders 56 shorter telomere length 56 carotid IMT 56 sd = 56 nonobstructive 56 depressive disorder 56 hypoactive 56 chronic renal insufficiency 56 nocturnal enuresis 56 DMARD 56 Posttraumatic stress disorder 56 concomitant medications 56 sinus node dysfunction 56 postoperative AF 56 multivariable analyzes 56 avoidant personality disorder 56 TT genotype 56 hypercoagulable 56 migraineurs 56 MADRS score 56 recurrent acute pancreatitis 56 hyperactivity inattention 56 Nocturia 56 CI #.#-#.# [001] 56 tic disorder 56 CVD mortality 56 bronchial hyperresponsiveness 56 pericardial effusion 56 oppositional defiant disorder 56 dyslipidaemia 56 PANSS scores 56 obstructive coronary artery 56 overactive bladder symptoms 56 BMI z 56 renal insufficiency 56 amisulpride 56 sociodemographic variables 56 mood disorders 56 % CI #.#-#.# [003] 56 probands 56 T1DM 56 potentially modifiable 56 parkinsonian 56 venlafaxine XR 56 onset seizures 56 PANSS 56 OAB symptoms 56 neurologic dysfunction 56 posttraumatic 55 neuropsychological impairment 55 asthma rhinitis 55 depressive disorders 55 hypomanic episodes 55 psychiatric disorder 55 antenatal depression 55 parkinsonism 55 diabetes dyslipidemia 55 subclinical cardiovascular disease 55 risperidone Risperdal 55 nondiabetic patients 55 neuroleptic 55 Obsessive compulsive disorder OCD 55 recurrent abdominal pain 55 BPRS 55 diastolic hypertension 55 enuresis 55 polyarticular 55 depression schizophrenia bipolar 55 attention-deficit/hyperactivity disorder ADHD 55 Univariate analysis 55 rhinoconjunctivitis 55 aetiology 55 DSM IV 55 cognitive affective 55 neurologic symptoms 55 CC genotype 55 salmeterol HFA MDI 55 generalized anxiety disorder GAD 55 pharmacologic treatments 55 neurologic disorders 55 dissociative disorders 55 carotid bruit 55 subclinical hyperthyroidism 55 neuropsychiatric symptoms 55 thrombophilia 55 ADCS CGIC 55 nonalcoholic steatohepatitis NASH 55 Posttraumatic stress disorder PTSD 55 #q#.# deletion syndrome 55 Atypical antipsychotics 55 hyperactive impulsive 55 atopic asthma 55 microscopic hematuria 55 suicide ideation 55 parasomnias 55 morphometric vertebral fractures 55 schizophreniform 55 neurocognition 55 airway responsiveness 55 neoplastic 55 Rating Scale BPRS 55 antiarrhythmic drug 55 untreated psychosis 55 etiologies 55 biochemical recurrence 55 antihypertensive therapy 55 Logistic regression analysis 55 posttreatment 55 HF hospitalization 55 citalopram 55 cerebral microbleeds 55 lowest tertile 55 neuropsychological assessment 55 esotropia 55 ischemic cardiomyopathy 55 thromboembolic 55 somnolence sleepiness 55 generalized epilepsy 55 β = 55 nasal polyposis 55 advanced neoplasia 55 depression irritability 55 impaired glucose metabolism 55 XIENCE V PROMUS Stent 55 AOR = 55 chronic prostatitis chronic 55 progressive dyspnea 55 EDSS scores 55 intracranial hypertension 55 hypoxemia 55 amnestic MCI 55 POAG 55 chronic obstructive lung 55 premenstrual dysphoric disorder 55 proliferative diabetic retinopathy 55 WOMAC pain 55 major depressive disorder 55 noncardiac 55 SSRI SNRI 55 INVEGA ® 55 hyperkinetic disorder 55 anxiety disorders 55 neuropsychological functioning 55 divalproex 55 CLBP 55 hypomanic episode 55 nonobese 55 convulsive disorders 55 CORE OM 55 LV dysfunction 55 clomipramine 55 paroxysmal AF 55 PLMs 55 Testosterone deficiency 55 systolic dysfunction 55 Multivariate analyzes 55 Mental Disorders DSM IV 54 RLS symptoms 54 neurodevelopmental impairment 54 P = .# 54 daytime drowsiness 54 hypertensives 54 autistic traits 54 ictal 54 microbleeds 54 perimenopausal women 54 sociodemographic 54 intravesical therapy 54 adnexal mass 54 SSRI citalopram 54 psychiatric outpatients 54 juvenile idiopathic arthritis 54 pretest probability 54 juvenile myoclonic epilepsy 54 concomitant AEDs 54 dyslipidemia hypertension 54 macrovascular disease 54 left ventricular hypertrophy 54 epididymitis 54 hematuria 54 neurologic impairment 54 nonsignificant 54 primidone 54 NIH CPSI 54 albumin excretion 54 endophenotypes 54 NYHA class 54 daytime sleepiness 54 schizotypal personality disorder 54 sensory gating 54 polyp recurrence 54 lipid lowering medications 54 depression suicidal ideation 54 hippocampal volumes 54 extensive metabolizers 54 confusional 54 generalized seizures 54 dopaminergic therapy 54 thyrotoxicosis 54 logistic regression models 54 PsA 54 hypertension dyslipidemia 54 CI -#.# 54 sotalol 54 subscores 54 atrophic gastritis 54 abdominal adiposity 54 β blocker 54 beta blocker therapy 54 oxycodone CR 54 disorder OCD 54 cognitively intact 54 fluoxetine paroxetine 54 erythrocyte sedimentation rate 54 fibroids endometriosis 54 SLNB 54 Subgroup analyzes 54 preoperative PSA 54 rebleeding 54 postoperative complication 54 nonfasting triglyceride levels 54 Bronchiectasis 54 multivariable analysis 54 coexisting illnesses 54 antisocial personality 54 severe hypoglycemia 54 intraventricular hemorrhage 54 hyperhomocysteinemia 54 myoclonic seizures 54 prognostic factors 54 etiological 54 mild renal insufficiency 54 cirrhotic 54 guideline concordant 54 subthreshold 54 tranylcypromine 54 psychotic illnesses 54 neuropathic 54 rheumatoid factor 54 Bacterial vaginosis 54 cervicitis 54 idiopathic generalized epilepsy 54 lamotrigine 54 histologic subtype 54 sleep disordered breathing 54 ATACAND 54 hypopneas 54 ADHF 54 peritumoral brain edema 54 left ventricular dysfunction 54 subclinical 54 CTEPH 54 NYHA functional class 54 lacunar 54 pathophysiologic 54 cardiovascular comorbidities 54 dyspnoea 54 constipation predominant 54 ziprasidone 54 aldosterone antagonist 54 Interpersonal psychotherapy 54 serotonin reuptake inhibitors 54 systemic corticosteroid 54 HbA 1c 54 antiepileptic drugs AEDs 54 tumor histology 54 Main Outcome Measures 54 Erythropoietic therapies may 54 overt nephropathy 54 acetabular dysplasia 54 rheumatoid arthritis osteoarthritis ankylosing 54 Y BOCS 54 quetiapine Seroquel 54 pathologic 54 proband 54 recurrent tonsillitis 54 psychopathological 54 prodromal 54 Abilify aripiprazole 54 impaired renal 54 dichotomized 54 white matter hyperintensities 54 familial clustering 54 perioperative complications 54 daytime alertness 54 microsatellite instability 54 clinically meaningful reductions 54 diagnosable disorder 54 polypharmacy 54 subcortical 54 bipolar affective disorder 54 unfavorable cytogenetics 54 comorbid ADHD 54 EDSS score 54 baseline HbA1c 54 neuroleptics 54 Conduct Disorder 54 somatoform 53 achieved statistical significance 53 tonsillar hypertrophy 53 neurologic abnormalities 53 Venous thromboembolism 53 pharmacologic therapies 53 rheumatologic 53 LVNC 53 induce orthostatic hypotension 53 dyspareunia 53 bivariate 53 electroencephalographic 53 esophageal motility 53 haloperidol Haldol 53 Socioeconomic status 53 hyperlipidaemia 53 airway hyperresponsiveness 53 pharmacotherapies 53 lupus erythematosus 53 constipation nausea 53 thyroid nodules 53 % Confidence Interval 53 dysfunctional voiding 53 hyperparathyroidism 53 hereditary predisposition 53 Rating Scale MADRS 53 behavioral disinhibition 53 diabetes hypertension hyperlipidemia 53 clinicopathological features 53 atrioventricular block 53 statistically significant predictor 53 periprocedural MI 53 multivariate logistic regression 53 silent myocardial ischemia 53 C trachomatis 53 Exacerbations 53 nocturia 53 HbA 1c levels 53 paranoid ideation 53 Diabetes mellitus 53 inotropic 53 cognitive dysfunctions 53 congenital adrenal hyperplasia 53 aortic regurgitation 53 cerebrovascular accidents 53 Prefrontal 53 diabetes mellitus hypertension 53 polygenic 53 unprovoked seizures 53 bipolar disorder schizophrenia 53 vesicoureteral reflux 53 voiding dysfunction 53 Endothelial dysfunction 53 carotid atherosclerosis 53 cognitive impairment associated 53 callous unemotional traits 53 adenomatous polyps 53 nonalcoholic steatohepatitis 53 tricyclic antidepressants 53 carotid intima media 53 Expanded Disability Status 53 osteochondroma 53 colorectal adenoma 53 headache abdominal pain 53 morbidities 53 posttransplant 53 tolterodine ER 53 cognitive dysfunction 53 Compulsive hoarding 53 paresthesias 53 Multivariate analysis 53 biopsychosocial 53 Quetiapine 53 advanced adenomas 53 hyperreflexia 53 hemiparesis 53 psychiatric inpatients 53 posttraumatic stress disorder PTSD 53 pain catastrophizing 53 apnea hypopnea index 53 depressive episodes associated 53 medically unexplained 53 SGRQ 53 postintervention 53 manic hypomanic 53 myocardial infarction MI 53 postdischarge 53 renal impairment 53 HAMD 53 underwent resection 53 lipid lowering agents 53 unmeasured confounders 53 UA NSTEMI 53 bacterial prostatitis 53 nontraumatic 53 dysglycemia 53 elevated serum creatinine 53 decompensated cirrhosis 53 subtrochanteric 53 PSQI 53 prolonged QT intervals 53 SGAs 53 cryptogenic 53 Raynaud syndrome 53 ischemic lesions 53 lipid abnormalities 53 Montgomery Asberg Depression 53 clozapine Clozaril 53 RLS sufferers 53 abnormal lipid 53 neurobehavioural 53 odds ratios ORs 53 mIU L 53 Postoperative complications 53 psychobiological 53 postoperative delirium 53 MDD 53 hypercholesterolaemia 53 status epilepticus 53 hepatocellular carcinomas 53 SCr 53 subependymal giant cell 53 myopia nearsightedness 53 colonic polyps 53 cerebral infarction 53 tic disorders 53 genital ulcer 53 autoimmune thyroiditis 53 p = 53 cognitive impairment 53 decompensated heart failure 53 hypertension congestive heart 53 hip BMD 53 serologically active patients 53 Daytime sleepiness 53 ALT flares 53 depressive episode 53 left ventricular diastolic 53 prescribed opioids 53 squamous histology 53 choroidal neovascularization 53 borderline personality disorder 53 elevated depressive symptoms 53 adenoidectomy 53 renal dysfunction 53 HADS 53 completely resected 53 univariate 53 Acute Stress Disorder 53 persistent pulmonary hypertension 53 quetiapine risperidone 53 orthostatic hypotension cataracts 53 susceptibility loci 53 albumin excretion rate 53 HBeAg negative 53 post transplant lymphoproliferative 53 sustained ventricular tachycardia 53 % CI #.#-#.# [002] 53 β blockers 53 nasal obstruction 53 Scale EDSS score 53 Infusion Reactions Severe 53 preserved ejection fraction 53 LV ejection fraction 53 narcolepsy cataplexy 53 multivariate analysis 53 P ≤ 53 ECOG PS 53 aripiprazole 53 Relapsing remitting MS 53 rheumatic disorders 53 LVSD 53 potential confounding variables 53 akinesia 53 hyperprolactinemia 53 radical prostatectomy RP 53 obstructive CAD 53 bipolar disorders 53 tonic clonic seizures 53 cardiovascular hospitalization 53 obstructive sleep 53 daytime somnolence 53 hemodynamically significant 53 gastro esophageal reflux disease 53 internalizing behaviors 53 polymicrobial infections 53 pT3 53 pulmonary exacerbations 53 PGTC seizures 53 Generalized anxiety disorder 53 #q# deletion 53 Nonalcoholic fatty liver 53 hypercalcemia 53 VLBW 53 subarachnoid hemorrhage SAH 53 insomnia somnolence 53 cardiac malformations 53 Schizophrenics 53 rs# [004] 53 RLAI 53 mild renal impairment 53 syncopal 53 histological subtype 53 polycythemia vera essential thrombocythemia 53 Parkinsonian Syndromes 53 opioid misuse 52 demyelinating 52 seminal vesicle invasion 52 geriatric syndromes 52 multifactorial 52 surveyed PCPs 52 sleep disturbances 52 Negative Syndrome 52 impulsivity characteristic 52 asthma exacerbation 52 acute subacute 52 venlafaxine Effexor 52 fluoxetine Prozac 52 asplenia 52 interobserver 52 Schizoaffective Disorder 52 oxygen desaturation 52 testicular tumors 52 SIADH 52 schizoaffective disorder 52 vitreous floaters 52 DAS# [002] 52 paroxysmal atrial fibrillation 52 TMP SMX 52 prospectively defined 52 Antisocial personality 52 Irritable bowel syndrome 52 cerebrovascular accident 52 Chronic constipation 52 hypercalciuria 52 prostate cancer CaP 52 airflow obstruction 52 dyspnea 52 adverse cytogenetics 52 thromboembolism 52 recurrent DVT 52 APOE genotype 52 manic depression bipolar disorder 52 PCa 52 symptom exacerbation 52 hemorrhagic cystitis 52 gestational diabetes mellitus 52 intraobserver 52 Nicotine dependence 52 adjunctive ABILIFY 52 TAVR 52 myocardial ischemia 52 polyuria 52 hyperactivity impulsivity 52 Pathological gambling 52 Knee osteoarthritis 52 Scale PANSS 52 reflux symptoms 52 squamous cell histology 52 Genetic predisposition 52 proximal colon 52 meta regression 52 ego dystonic 52 heterozygous familial 52 Korsakoff syndrome 52 HIV HCV coinfected 52 nonischemic 52 analgesic medications 52 vWD 52 macular edema secondary 52 laboratory abnormalities 52 estimated GFR 52 coronary artery aneurysms 52 Neuropsychiatric Inventory NPI 52 Structured Clinical 52 prostatic hyperplasia 52 coronary stenosis 52 Pervasive Developmental Disorder 52 coinfected patients 52 tiagabine 52 IgA deficiency 52 antidepressant monotherapy 52 dysarthria 52 attain statistical significance 52 neuropsychiatric disorder 52 metformin monotherapy 52 asymptomatic PAD 52 interpersonal psychotherapy 52 APOE ε4 52 FDG uptake 52 body dysmorphic disorder 52 bosentan 52 impaired fasting glucose 52 hypertension hypercholesterolemia 52 atypical antipsychotic medications 52 adjunctive placebo 52 CI #.#-#.# [002] 52 etiologic 52 posttraumatic stress disorder 52 Bipolar Mania 52 QIDS SR 52 upper airway obstruction 52 Prehypertension 52 rufinamide 52 confounding variables 52 AGILECT R 52 Pneumocystis carinii pneumonia 52 anthracycline containing 52 recurrent ischemia 52 hypercholesterolemia 52 pT2 52 COPD emphysema 52 rCBF 52 pharmacological intervention 52 acne vulgaris 52 myocardial infarction stroke 52 EORTC QLQ C# 52 proliferative retinopathy 52 CP CPPS 52 bothersome symptom 52 hypoglycemic events 52 warfarin erythromycin 52 Hurthle cell 52 anhedonia 52 intermittent exotropia 52 Index CDAI 52 delusions hallucinations 52 allergic sensitization 52 emotional dysregulation 52 variceal bleeding 52 endometrial thickness 52 extrapyramidal disorder 52 node metastases 52 noncardiovascular mortality 52 lifetime abstainers 52 insomnia dizziness 52 antiepileptic medications 52 antiepileptics 52 hallux valgus 52 nondemented 52 Chronic Heart Failure 52 idiopathic PAH 52 atypical hyperplasia 52 Predictors 52 clinicopathologic 52 advanced adenoma 52 familial hypercholesterolemia 52 diathesis 52 Socio demographic 52 Pelvic inflammatory 52 causal pathway 52 sensory neuropathy 52 microvascular disease 52 paraneoplastic 52 angiographically 52 detrusor 52 HNSCC 52 medication nonadherence 52 desvenlafaxine succinate 52 monoclonal gammopathy 52 sedatives hypnotics 52 preoperative diagnosis 52 bipolar illness 52 Primary IGFD 52 coronary artery calcification 52 congenital anomalies 52 collagen vascular 52 mg BID dose 52 EFFEXOR XR 52 coagulopathy 52 hypophosphatemia 52 myeloproliferative neoplasms 52 epilepsies 52 depressive episodes 52 ADPKD 52 Main Outcome Measure 52 subthreshold depression 52 Zollinger Ellison syndrome 52 NIHSS 52 Secondary endpoints 52 anaphylaxis angioedema 52 Binge eating 52 anticonvulsant medications 52 carotid plaques 52 hyperlipidemia 52 DAS# CRP 52 BMI ≥ 52 = #.#-#.# 52 MACCE 52 UPDRS 52 Symptom Checklist 52 nonoperative treatment 52 Stent thrombosis 52 abstinent alcoholics 52 moderate renal impairment 52 coexistent 52 nonmalignant 52 elevated triglycerides 52 peptic ulcer 52 logistic regression 52 hematologic toxicity 52 benign breast 52 colorectal neoplasms 52 adrenal insufficiency 52 mood dysregulation 52 sacral neuromodulation 52 enthesitis 52 untreated celiac disease 52 onset diabetes mellitus 52 DQB1 * 52 Depressive disorders 52 neutropaenia 52 highest tertile 52 neurological abnormalities 52 Primary endpoints 52 psychoeducation 52 underlying pathophysiology 52 malignant neoplasm 52 atopic disorders 52 hypogonadotropic hypogonadism 52 left ventricular systolic 52 postoperative morbidity 52 pediatric bipolar disorder 52 neurologic complications 52 tumor necrosis 52 etiology 52 cerebral infarctions 52 FEV ^ sub 52 Autistic Disorder 52 polyposis 52 AA Amyloidosis 52 hyperacute 52 elevated fasting glucose 52 recurrent wheezing 52 quetiapine XR 52 hypopituitarism 52 Chronic Migraine 52 events TEAEs 52 quetiapine 52 temporal lobectomy 52 agomelatine 52 procedural sedation 52 conventional antipsychotics 52 Chronic ITP 52 GERD symptoms 52 pyrexia mucositis sepsis febrile 52 Sleep disordered breathing 52 generalized anxiety 52 mRS 52 extracranial 52 acutely decompensated congestive heart 52 Impulsivity 52 coronary calcification 52 STEP BD 52 hepatic insufficiency 52 Mental Disorders Fourth 52 hematopoietic cancers 52 psychometric properties 52 APTIVUS r 52 neurologic disorder 52 mood swings irritability 52 abnormal lipids 52 pentoxifylline 52 fibromyalgia syndrome 52 VIIBRYD 52 oxcarbazepine 52 undergoing radical cystectomy 52 femoral neck fracture 52 IOP lowering 52 fragility fracture 51 acute myocardial infarction congestive 51 anorexia sufferers 51 ADHD symptoms 51 elevated ALT 51 intact parathyroid hormone 51 irritability mood swings 51 SSRI antidepressant 51 atopy 51 erection hardness 51 Asymptomatic 51 schizophrenia 51 hyperammonemia 51 Sleep disturbances 51 Not Otherwise Specified 51 isolated systolic hypertension 51 prodrome 51 lymphocytic 51 delayed gastric emptying 51 sertraline Zoloft 51 psychomotor agitation 51 extrapyramidal side 51 vestibular dysfunction 51 depression suicidality 51 lupus scleroderma